ISPOR OUTLINES NEW STRATEGIC VISION AT 18th ANNUAL EUROPEAN CONGRESS

Published Nov 10, 2015

ISPOR UPDATES STRATEGY IN ITS 20th ANNIVERSARY YEAR 

Milan, Italy—November 10, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) outlined the organization’s updated strategic vision this morning during its member meeting at the 18th Annual European Congress in Milan, Italy. ISPOR President Daniel C. Malone, RPh, PhD and CEO Nancy Berg presented ISPOR’s new organizational strategy, an update of ISPOR’s Vision 2020, the current strategic plan. ISPOR’s new Mission Statement to promote health economics and outcomes research excellence to improve decision making for health globally is supported by five strategic pillars:
  1. Scientific and Research Excellence
  2. Member Engagement
  3. Education and Training
  4. Communication and Collaboration
  5. Organizational Values
“We are very excited to introduce ISPOR’s new strategic vision to our members,” noted Berg. “Our updated strategy was developed by ISPOR’s Strategic Planning Working Group and approved by the ISPOR Board with input from many members.” In his comments, Malone emphasized the Society’s commitment to strengthen the integrity, advancement, and understanding of health economics and outcomes research globally. Additional information on ISPOR’s updated strategic vision may be found at http://www.ispor.org/mission.asp. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.

###

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×